OptiBiotix Health (LON:OPTI) Posts Quarterly Earnings Results

OptiBiotix Health (LON:OPTI) released its earnings results on Thursday. The company reported GBX (3.84) earnings per share for the quarter, Digital Look Earnings reports. The firm had revenue of GBX 117 million during the quarter. OptiBiotix Health had a negative return on equity of 2.27% and a negative net margin of 16.59%.

OptiBiotix Health Price Performance

LON:OPTI opened at GBX 6.30 on Thursday. OptiBiotix Health has a fifty-two week low of GBX 4.50 and a fifty-two week high of GBX 15. The stock’s 50-day moving average is GBX 5.32 and its two-hundred day moving average is GBX 6.36. The stock has a market cap of £6.51 million, a PE ratio of -209.97 and a beta of 1.71.

OptiBiotix Health Company Profile

OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.

OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.

OptiBiotix is also developing its own range of consumer supplements and health products.